Express News | A subsidiary of Hybio Pharmaceutical has signed a Global Strategy cooperation agreement with Longma Technology.

BreakingsDec 11 13:00

The A-share weight loss drug sector rose, with hebei changshan biochemical pharmaceutical increasing by over 10%.

On December 10, Glodon reported that Hebei Changshan Biochemical Pharmaceutical rose over 10%, with Hybio Pharmaceutical, Shengnuo Biotech, Hongyuan Pharmaceutical, Brightgene Bio-medical Technology Co., Ltd. and others rising as well. In terms of news, the oral version of Semaglutide launched its nationwide pre-sale on Meituan at 9 PM on December 9. At the same time, Tirzepatide, recognized by the industry as the 'strongest competitor' to Semaglutide, also started its first reservation on Meituan. In some areas, users can make appointments for weight management at local clinics, and there are reports that within a week, a home delivery service for medication will also be available for booking.

Gelonghui FinanceDec 10 11:08

Express News | Hybio Pharmaceutical: Signed a 0.102 billion yuan GLP-1 active pharmaceutical ingredient supply agreement with DS3.

BreakingsDec 5 18:57

Express News | Hybio Pharmaceutical: has again received an order for the procurement of Hikma's Liraglutide injection.

BreakingsDec 4 18:25

Concept mining | Simgeglutide weight loss drug officially launched in China, multiple e-commerce platforms have gone online

The market has broad prospects

Gelonghui FinanceNov 17 14:35

Express News | hybio pharmaceutical: Former director Yuan Jiancheng was finally sentenced for embezzlement and sentenced to three years and six months in prison.

BreakingsNov 13 18:19